Clinical Trial

Continuous Glucose Monitor Use in Pregnancy

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to perform a randomized controlled trial among 180 pregnant women with type 2 diabetes mellitus (T2DM) comparing continuous glucose monitor (CGM) use to the standard of care of multiple daily fingerstick glucose monitoring and its impact on large for gestational age infants, maternal glycemic control, patient satisfaction, and additional adverse perinatal outcomes.
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-07-01 -> 2026-12-31 2026-08-04
Trial Details
NCT Number NCT05317585
Lead Sponsor University of Massachusetts, Worcester
Conditions Type 2 Diabetes Treated With Insulin, Pregnancy, High Risk
Enrollment 180 participants
Start Date 2024-05-23
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-03